marijuana stock news

Alkaline Water To Launch CBD Topicals Line, E-Commerce Platform

The Alkaline Water Company (NASDAQ: WTER) launched its own line of CBD topical products, including balms, bath salts, lotions, essential oils, and salves, all made with full-spectrum hemp under the brand name, A88CBD.

The company plans to launch a new e-commerce website dedicated solely to the sale of its topical CBD products. The company said the expected launch date of the e-commerce website will be Feb. 20.

“This is another major milestone for our company as we push towards becoming a national lifestyle brand,” said Ricky Wright, CEO of The Alkaline Water Company. “We have worked diligently over the past 24 months to develop the best CBD offerings in the marketplace and are thrilled to announce our hard work.

“The E-commerce launch is happening on the heels of a tremendous ECRM CBD Topical show. Our brick and mortar retail clients showed tremendous interest in our A88CBD™ Topicals at the show and we expect to receive orders immediately. We know that almost 50% of all shoppers will participate in E-commerce this year and we consider this platform, and our partnership with a modern full-service agency such as YouTech, to be a major driver for our 2020 CBD business.”


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Neutra Corp. (NTRR) VIVIS Gives Website Visitors Fascinating Peek into CBD Extraction

Neutra Subsidiary VIVIS Gives Website Visitors Fascinating Peek into CBD Extraction  While…

Enertopia Corporation (ENRT) Sample Preparation Underway for Solution Testing

Enertopia Sample Preparation Underway for Solution Testing Enertopia Corporation (OTCQB: ENRT; CSE:…

Terra Tech Corp. (TRTC) CEO to Participate in Cannabis Industry Panel and Host Company Presentation

Terra Tech Corp. CEO to Participate in Cannabis Industry Panel and Host…

 Tetra Bio-Pharma Inc. (TBPMF) Survey Validates Primary Endpoint of SERENITY© Clinical Trial

Tetra Biopharma Survey Validates Primary Endpoint of SERENITY© Clinical Trial    Tetra…